跳至内容

通过 FDA 获得抑郁症检测人工智能并不容易

在过去的七年里,总部位于加州的初创公司 Kintsugi 一直在开发人工智能,旨在从一个人的言语中检测抑郁和焦虑的迹象。但在未能及时获得 FDA 批准后,该公司即将关闭并......

schedule 15:33 visibility 20 浏览
通过 FDA 获得抑郁症检测人工智能并不容易
来源: The Verge 阅读原文 →

auto_awesome 本文由机器自动翻译,可能存在不准确之处。

A vintage computer on a background of 1s and 0s with a brain on the screen representing AI

For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person's speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some elements may even find a second life beyond healthcare, like detecting deepfake audio.

Mental health assessments still largely rely on patient questionnaires and clinical interviews, rather than the lab tests or scans common in physical medicine. Instead of focusing on what someone is saying, Kintsugi's software analyzes how it is being said. Th …

Read the full story at The Verge.